Cite Filings / ANTX
Feed Companies Filings Check
Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Filings Insiders Search text
All 387 Financials 61 Shareholder Meetings 5 Executive Compensation 50 Insider Trading 216 Beneficial Ownership Interest 49 Business Combinations 41 Public Offerings 17 Mutual Funds and ETFs 4 Others 43
›
Filed in
  1. No filings match these filters. Clear filters
  2. DRSLTR Other Correspondence Related to Draft Registration Statement 2022-01-19
  3. DRS/A Other Draft Registration Statement 2022-01-19
  4. UPLOAD Other SEC-generated Letter 2021-12-03
  5. DRS/A Other Draft Registration Statement 2021-11-19
  6. DRSLTR Other Correspondence Related to Draft Registration Statement 2021-11-18
  7. UPLOAD Other SEC-generated Letter 2021-10-22
  8. DRS Other Draft Registration Statement 2021-09-24

Page 20 of 20 · 387 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…